Matthew M. Endo

884 citations
9 papers · 681 indexed · 1 hit paper · h-index 6
Topics
Antifungal resistance and susceptibility (6 papers)Essential Oils and Antimicrobial Activity (2 papers)Fungal Biology and Applications (2 papers)
Partner nations
United States

In The Last Decade

Matthew M. Endo

9 papers receiving 670 citations

Hit Papers

Amphotericin primarily kills yeast by simply binding ergo...20122026201620212012100200300400

Peers

Matthew M. Endo
Comparison fields: 5 of 74
  • Infectious Diseases 289
  • Molecular Biology 268
  • Organic Chemistry 173
  • Epidemiology 166
  • Pharmacology 130
Replace Daniel S. Palacios with:
Daniel S. Palacios United States
Kaitlyn Gray United States
Thomas M. Anderson United States
Brice E. Uno United States
Lynn Miesel United States
Eugenia N. Olsufyeva Russia
Ricardo Gallardo‐Macias United States
Gayathri Nagalingam Australia
Anatoly Severin United States
Małgorzata Bondaryk Poland
Matthew M. Endo relative to Daniel S. Palacios United States Daniel S. Palacios's profile →
Citations per field
00.5×1.6×
Daniel S. Palacios · 1×
Citations per year

Countries citing papers authored by Matthew M. Endo

Since Specialization
Citations

This map shows the geographic impact of Matthew M. Endo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew M. Endo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew M. Endo more than expected).

Fields of papers citing papers by Matthew M. Endo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew M. Endo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew M. Endo. The network helps show where Matthew M. Endo may publish in the future.

Co-authorship network of co-authors of Matthew M. Endo

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew M. Endo. A scholar is included among the top collaborators of Matthew M. Endo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew M. Endo. Matthew M. Endo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
#WorkIndexed citations
1
Synthesis-enabled understanding of the mechanism of action of amphotericin B and the development of increased therapeutic derivatives
1
2 73
3
Nontoxic antimicrobials that evade drug resistance
1
4 13
5 89
6
Amphotericin primarily kills yeast by simply binding ergosterolbreakdown →
442
7 22
8 39
9
[Application of an antifungal antibiotic (kabicidin) in cultures of cells].
1

About Matthew M. Endo

Matthew M. Endo is a scholar working on Infectious Diseases, Pharmacology and Microbiology, having authored 9 papers that have together received 681 indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (6 papers), Essential Oils and Antimicrobial Activity (2 papers) and Fungal Biology and Applications (2 papers). The work is most often cited by research in Infectious Diseases (289 citations), Microbiology (69 citations) and Pharmacology (130 citations). Matthew M. Endo has collaborated with scholars based in United States. Frequent co-authors include Martin D. Burke, Brice E. Uno, Daniel S. Palacios, Kaitlyn Gray, Karen Marchillo, Benjamin Vincent, David R. Andes, Stephen Davis, Luke Whitesell and Susan Lindquist. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of the American Chemical Society and Nature Chemical Biology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026